Michael G. Hahn

1.5k total citations
26 papers, 1.1k citations indexed

About

Michael G. Hahn is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael G. Hahn has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael G. Hahn's work include Nitric Oxide and Endothelin Effects (12 papers), Renin-Angiotensin System Studies (5 papers) and Stress Responses and Cortisol (4 papers). Michael G. Hahn is often cited by papers focused on Nitric Oxide and Endothelin Effects (12 papers), Renin-Angiotensin System Studies (5 papers) and Stress Responses and Cortisol (4 papers). Michael G. Hahn collaborates with scholars based in Germany, United States and Australia. Michael G. Hahn's co-authors include Joachim Mittendorf, Johannes‐Peter Stasch, Johannes-Peter Stasch, Markus Follmann, Alexander Kühl, Miljenko Dumić, David S. Celermajer, Roland Stocker, Gavin McKenzie and Yutang Wang and has published in prestigious journals such as Nature, Angewandte Chemie International Edition and Nature Medicine.

In The Last Decade

Michael G. Hahn

25 papers receiving 1.1k citations

Peers

Michael G. Hahn
Rina Recchioni Italy
Fiorella Marcheselli Italy
Sipra Saha Sweden
Yohsuke Minatogawa Japan
Fernando Benito Bartolomé Spain
Adriana Souza Torsoni Brazil
Nancy L. Reichenbach United States
Yanbin Ji United States
Samuel A.J. Trammell Denmark
Marta Tajes Spain
Rina Recchioni Italy
Michael G. Hahn
Citations per year, relative to Michael G. Hahn Michael G. Hahn (= 1×) peers Rina Recchioni

Countries citing papers authored by Michael G. Hahn

Since Specialization
Citations

This map shows the geographic impact of Michael G. Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Hahn more than expected).

Fields of papers citing papers by Michael G. Hahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Hahn. The network helps show where Michael G. Hahn may publish in the future.

Co-authorship network of co-authors of Michael G. Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Hahn. A scholar is included among the top collaborators of Michael G. Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Hahn. Michael G. Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kraehling, Jan R., Agnès Bénardeau, Tibor Schomber, et al.. (2023). The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats. International Journal of Molecular Sciences. 24(17). 13226–13226. 7 indexed citations
2.
Hahn, Michael G., Martina Delbeck, Lisa Dietz, et al.. (2022). Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC. Respiratory Research. 23(1). 272–272. 10 indexed citations
3.
Bénardeau, Agnès, Antje Kahnert, Tibor Schomber, et al.. (2021). Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(12). 2363–2379. 24 indexed citations
4.
Sandner, Peter, Markus Follmann, Michael G. Hahn, et al.. (2021). Soluble GC stimulators and activators: Past, present and future. British Journal of Pharmacology. 181(21). 4130–4151. 67 indexed citations
5.
Bénardeau, Agnès, Michael G. Hahn, Michael Gerisch, et al.. (2020). The Novel Soluble Guanylyl Cyclase (sGC) Activator Runcaciguat Induced Renal Vasodilation and Reduced Kidney Damage in a Rat CKD Model. Journal of the American Society of Nephrology. 31(10S). 232–232. 1 indexed citations
6.
Hahn, Michael G., et al.. (2020). Tyrosine 135 of the β1 subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs. European Journal of Pharmacology. 881. 173203–173203. 7 indexed citations
7.
Bénardeau, Agnès, Johannes‐Peter Stasch, Michael G. Hahn, et al.. (2020). The Novel Soluble Guanylyl Cyclase (sGC) Activator Runcaciguat Attenuates Hypertensive Cardiorenal Rat Diseases. Journal of the American Society of Nephrology. 31(10S). 244–244. 1 indexed citations
8.
Rödström, Karin E. J., Aytuğ K. Kiper, Wei Zhang, et al.. (2020). A lower X-gate in TASK channels traps inhibitors within the vestibule. Nature. 582(7812). 443–447. 54 indexed citations
9.
Bénardeau, Agnès, Johannes‐Peter Stasch, Michael G. Hahn, et al.. (2020). The Novel Soluble Guanylyl Cyclase (sGC) Activator Runcaciguat Improves Cardiorenal Morbidity in a Diabetic Rat Model of CKD. Journal of the American Society of Nephrology. 31(10S). 318–318. 1 indexed citations
10.
Follmann, Markus, Nils Griebenow, Michael G. Hahn, et al.. (2013). The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators. Angewandte Chemie International Edition. 52(36). 9442–9462. 159 indexed citations
11.
Follmann, Markus, Nils Griebenow, Michael G. Hahn, et al.. (2013). Chemie und Biologie der Stimulatoren und Aktivatoren der löslichen Guanylatcyclase. Angewandte Chemie. 125(36). 9618–9639. 3 indexed citations
12.
Kumar, Vijay, Emil Martin, Michael G. Hahn, et al.. (2013). Insights into BAY 60-2770 Activation and S-Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes. Biochemistry. 52(20). 3601–3608. 54 indexed citations
13.
Hirth‐Dietrich, Claudia, Cristina Alonso‐Alija, Michael Härter, et al.. (2011). Nitric Oxide-independent Activation of Soluble Guanylate Cyclase by BAY 60-2770 in Experimental Liver Fibrosis. Arzneimittelforschung. 58(2). 71–80. 70 indexed citations
14.
Wang, Yutang, Hanzhong Liu, Gavin McKenzie, et al.. (2010). Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nature Medicine. 16(3). 279–285. 355 indexed citations
15.
Wang, Yutang, Gavin McKenzie, Paul K. Witting, et al.. (2009). Kynurenine is a novel endothelium-derived vascular relaxing factor produced during inflammation. BMC Pharmacology. 9(S1). 2 indexed citations
16.
Wang, Yutang, Gavin McKenzie, Johannes‐Peter Stasch, et al.. (2009). Is kynurenine a novel and important vasodilator in human septic shock?. BMC Pharmacology. 9(S1). 1 indexed citations
17.
Hahn, Michael G., Cristina Alonso‐Alija, Friederike Stoll, et al.. (2007). Design and synthesis of the first NO- and haem-independent sGC activator BAY 58–2667 for the treatment of acute decompensated heart failure. BMC Pharmacology. 7(S1). 4 indexed citations
18.
Kühl, Alexander, Michael G. Hahn, Miljenko Dumić, & Joachim Mittendorf. (2005). Alicyclic β-amino acids in Medicinal Chemistry. Amino Acids. 29(2). 89–100. 109 indexed citations
19.
20.
Maschwitz, U., et al.. (1979). Neue Abdominaldrüsen bei Ameisen. Zoomorphologie. 94(1). 49–66. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rina Recchioni Breakdown of academic impact, for papers by Fiorella Marcheselli Breakdown of academic impact, for papers by Sipra Saha Breakdown of academic impact, for papers by Yohsuke Minatogawa Breakdown of academic impact, for papers by Fernando Benito Bartolomé Breakdown of academic impact, for papers by Adriana Souza Torsoni Breakdown of academic impact, for papers by Nancy L. Reichenbach Breakdown of academic impact, for papers by Yanbin Ji Breakdown of academic impact, for papers by Samuel A.J. Trammell Breakdown of academic impact, for papers by Marta Tajes
Rankless by CCL
2026